Breaking News

Stiefel Patents

July 10, 2006

Patent No. US 7,022,332 B2: Sulf- acetamide formulations for treatment of rosacea have been assigned to Stiefel Laboratories, Inc., Oak Hill, NY. The products are topical compositions for the treatment of mammalian skin dermatoses comprising at least one sulfacetamide or a derivative thereof and at least one sunscreen.

blog comments powered by Disqus